@article{64b1c5b2f0da4b1b9036188436090ea3,
title = "Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma",
author = "Demierre, \{Marie France\} and Josephine Taverna",
note = "Funding Information: Disclosure: Dr Demierre has a significant interest in the impact of pruritus on patients with cutaneous T-cell lymphoma. In December 2005 she completed a small study of 12 patients, titled {\textquotedblleft}Assessment of Pruritus and Health-related Quality of Life Measures in Patients with Cutaneous T-Cell Lymphoma (CTCL).{\textquotedblright} This study was sponsored by Merck. Both drugs discussed in this letter are not manufactured by Merck. ",
year = "2006",
month = sep,
doi = "10.1016/j.jaad.2006.04.025",
language = "English (US)",
volume = "55",
pages = "543--544",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Elsevier Inc.",
number = "3",
}